Page last updated: 2024-12-08

o-succinylhomoserine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O-succinylhomoserine: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID439406
CHEBI ID16160
SCHEMBL ID2263150
MeSH IDM0062537

Synonyms (37)

Synonym
CHEBI:16160
(2s)-2-amino-4-(3-carboxypropanoyloxy)butanoic acid
l-homoserine, hydrogen butanedioate (ester)
succinic acid, monoester with l-2-amino-4-hydroxybutyric acid
butanedioic acid, mono(3-amino-3-carboxypropyl) ester
butanedioic acid, mono(3-amino-3-carboxypropyl) ester, (s)-
succinic acid, monoester with l-2-amino-4-hydroxybutyric acid (8ci)
butanedioic acid, mono[(3s)-3-amino-3-carboxypropyl] ester
butyric acid, 2-amino-4-hydroxy-, hydrogen succinate (ester), l- (8ci)
succinic acid, ester with 2-amino-4-hydroxybutyric acid (7ci)
butyric acid, 2-amino-4-hydroxy-, hydrogen succinate (ester), l-
l-homoserine, hydrogen butanedioate (ester) (9ci)
succinic acid, monoester with 2-amino-4-hydroxybutyric acid
succinic acid, ester with 2-amino-4-hydroxybutyric acid
o-succinyl-homoserine
1492-23-5
o4-succinyl-l-homoserine
o-succinylhomoserine
C01118
O-SUCCINYL-L-HOMOSERINE ,
BMSE000058
2-amino-4-(4-hydroxy-4-oxobutanoyl)oxybutanoic acid
AM806589
(s)-2-amino-4-((3-carboxypropanoyl)oxy)butanoic acid
AKOS022183836
SCHEMBL2263150
l-homoserine, 4-(hydrogen butanedioate)
DTXSID60164192
HY-119543
J-008569
o-(3-carboxypropanoyl)-l-homoserine
Q27098406
F82284
MS-23210
2-amino-4-((3-carboxypropanoyl)oxy)butanoic acid
STARBLD0017133
CS-0068700
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
o-succinylhomoserine
hemisuccinateA succinate ester in which only one of the carboxy groups of succinic acid has been esterified.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Methionine Biosynthesis1018
Selenocompound Metabolism923
superpathway of lysine, threonine and methionine biosynthesis I038
methionine biosynthesis I017

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (26.32)18.7374
1990's5 (26.32)18.2507
2000's2 (10.53)29.6817
2010's3 (15.79)24.3611
2020's4 (21.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.94 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.85 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]